chr19-18155913-C-G
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_005027.4(PIK3R2):c.34C>G(p.Leu12Val) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000142 in 1,412,628 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_005027.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
PIK3R2 | NM_005027.4 | c.34C>G | p.Leu12Val | missense_variant | Exon 2 of 16 | ENST00000222254.13 | NP_005018.2 | |
PIK3R2 | NR_073517.2 | n.589C>G | non_coding_transcript_exon_variant | Exon 2 of 16 | ||||
PIK3R2 | NR_162071.1 | n.589C>G | non_coding_transcript_exon_variant | Exon 2 of 15 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
PIK3R2 | ENST00000222254.13 | c.34C>G | p.Leu12Val | missense_variant | Exon 2 of 16 | 1 | NM_005027.4 | ENSP00000222254.6 | ||
ENSG00000268173 | ENST00000593731.1 | n.34C>G | non_coding_transcript_exon_variant | Exon 2 of 25 | 2 | ENSP00000471914.1 |
Frequencies
GnomAD3 genomes Cov.: 33
GnomAD4 exome AF: 0.00000142 AC: 2AN: 1412628Hom.: 0 Cov.: 31 AF XY: 0.00000286 AC XY: 2AN XY: 698462
GnomAD4 genome Cov.: 33
ClinVar
Submissions by phenotype
Inborn genetic diseases Uncertain:1
The c.34C>G (p.L12V) alteration is located in exon 2 (coding exon 1) of the PIK3R2 gene. This alteration results from a C to G substitution at nucleotide position 34, causing the leucine (L) at amino acid position 12 to be replaced by a valine (V). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at